RazorMetrics Welcomes Akshay Bhandari as New General Manager and CFO to Fuel Growth

On September 3, 2025, RazorMetrics, an industry leader in pharmacy cost reduction solutions, announced that Akshay Bhandari has taken on the role of General Manager and Chief Financial Officer (CFO). Bhandari, who joined the RazorMetrics team in June 2025, will play a critical role in steering the company’s business and financial strategies while guiding revenue operations as they embark on their next growth phase.

Bhandari is recognized for his unique blend of finance acumen and operational leadership, which proved essential for RazorMetrics as it scales to new heights. According to Tom Dorsett, the company’s CEO, Bhandari’s extensive background in managing financial operations and complex strategies will significantly contribute to both the leadership team and their clients. Dorsett stated, “Akshay brings a rare combination of investment and finance expertise as well as operational leadership that is exactly what RazorMetrics needs as we continue to scale. His track record of guiding organizations through expansion and complex financial strategies will be a tremendous asset to our team.”

Bhandari initiated his career at Citigroup Global Markets in investment banking before transitioning into venture capital and private equity with firms such as Battery Ventures and Stripes Group. During his tenure in private equity, he successfully facilitated investments in notable companies including Seamless.com, Turtle Beach, and Sandata Technologies. His career progressed at Sandata, where he began as Director of Business Development and Strategy and was later appointed CFO, significantly contributing to the company’s growth and overseeing numerous buy and sell-side transactions.

In remarks regarding his new role, Bhandari expressed enthusiasm about being part of RazorMetrics at such a pivotal time in the company’s journey. He noted, “RazorMetrics is at a pivotal point in its growth, and I am honored to join the team at such an exciting time. The company's mission to improve affordability and access to prescription drugs resonates deeply with me. The RazorMetrics team has built a strong, innovative culture that thrives on helping customers succeed. I look forward to helping guide the organization through its next phase of growth.”

RazorMetrics has been experiencing a surge of momentum, recently being ranked No. 18 on the 2025 Inc. 5000 list of the fastest-growing companies in America. This recognition underscores the rising demand for innovative, cost-saving solutions within the healthcare sector, showcasing RazorMetrics as a front-runner in healthcare technology innovation.

RazorMetrics is dedicated to developing advanced pharmacy cost containment solutions designed to efficiently and effectively reduce drug costs. The company's technology works seamlessly to identify cost-saving opportunities through strategies such as medication switching, deprescribing, deduplication, and more. With adaptability to align with various client plans, preferences, and formularies, RazorMetrics integrates smoothly into the workflows of prescribers, which enhances healthcare decision-making while also minimizing medication costs for members and plan sponsors.

Based in Austin, Texas, RazorMetrics aims to deliver clarity, efficiency, and enhanced value to pharmacy benefits. Learn more about their offerings and mission at razormetrics.com.

For media inquiries, please contact Kat Long at [email protected] for further details and insights regarding RazorMetrics’ latest appointment and its impact on the company's future.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.